Abstract
BackgroundCurrently, the diagnosis of chronic obstructive pulmonary disease (COPD) is not uniform, COPD guidelines recommend fixed ratio (FR), whereas ATS and ERS define airflow obstruction based on lower limit of normal (LLN). We aim to determine if there is difference between the two diagnostic criteria for morbidity, mortality, exacerbation.MethodsFour databases and all relevant studies from the references were searched from inception to June 25, 2019, to find studies that described the rate of comorbidity, the exacerbation rates, mortality in COPD patients. Data analysis was performed using STATA/SE 14.0 and followed the standard of Cochrane Collaboration. A sensitivity analysis was performed to find the source of heterogeneity.ResultsThirteen studies and 154,447 participants were finally included in this meta-analysis. The 11 cohort studies and 2 cross-sectional studies were all high-quality. Patients with airflow limitation according to either FR or LLN had higher mortality (HRFR+/LLN- = 1.27, 95% CI = 1.14–1.42; HRFR−/LLN+ = 1.83, 95% CI = 1.17–2.86) than those who met neither criteria. When compared with the FR−/LLN- criteria, those who met the FR criteria were more likely to exacerbate (HR FR+/LLN- = 1.64, 95% CI = 1.09–2.46; HR FR−/LLN+ = 1.58, 95% CI = 0.70–3.55). The meta-analysis for comorbidities showed no significant difference between patients who met neither criteria and those who met LLN or FR criteria.ConclusionThe patients with airflow limitations according to FR were more likely to exacerbate than those with LLN only. Patients that met either FR or LLN were more likely to have higher mortality than FR−/LLN-. There was no difference between the FR+/LLN- and FR−/LLN+ groups for the occurrence of comorbidities.
Highlights
The diagnosis of chronic obstructive pulmonary disease (COPD) is not uniform, COPD guidelines recommend fixed ratio (FR), whereas American Thoracic Society (ATS) and European Respiratory Society (ERS) define airflow obstruction based on lower limit of normal (LLN)
In 2015, 99.9 million Chinese were diagnosed with COPD, which accounted for 8.6% of the total population [4]
Our analysis found that when compared with patients who didn’t meet any criterion, there was no significant difference with those who met 1 or 2 criteria (OR FR+/LLN+ = 1.30, 95% Confidence Interval (CI) = 0.87–1.93; odds ratio (OR) FR+/LLN- = 1.68, 95% CI = 0.99–2.84; OR FR−/LLN+ = 1.16, 95% CI = 0.87–1.55) (Fig. 4)
Summary
The diagnosis of chronic obstructive pulmonary disease (COPD) is not uniform, COPD guidelines recommend fixed ratio (FR), whereas ATS and ERS define airflow obstruction based on lower limit of normal (LLN). Chronic obstructive pulmonary disease (COPD) is a non-curable disease with high morbidity and mortality [1]. It is the 3rd leading cause of death [2]. In America in the 2000s, the prevalence of COPD was 24 million, and half of these were undiagnosed [3]. Several co-morbidities of COPD, such as cardiovascular disease and diabetes mellitus have been reported to exacerbate the mortality of COPD [6, 7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
